Oleamide

Oleamide

SCHEMBL2906344

CC(C)N.CCCCCCCCC=CCCCCCCCC(N)=O

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.85
SOAT1 P35610 2/20 0.85
CYP1A2 P05177 2/20 0.85
CYP2C19 P33261 2/20 0.85
KMT2A Q03164 2/20 0.85
MEN1 O00255 1/20 0.85
TP53 P04637 1/20 0.85
CYP3A4 P08684 1/20 0.85
KDM4E B2RXH2 2/20 0.77
CNR1 P21554 1/20 0.68
TERT O14746 3/20 0.61
PTPN1 P18031 3/20 0.61
PPARG P37231 3/20 0.61
PPARD Q03181 3/20 0.61
PPARA Q07869 3/20 0.61
MAPT P10636 2/20 0.61
BLM P54132 2/20 0.61
HSD17B10 Q99714 2/20 0.61
FABP4 P15090 2/20 0.61
GMNN O75496 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleamide SCHEMBL6366127 0.93 FAAH (0.85) FAAHSOAT1CYP1A2CYP2C19KMT2A
Oleamide SCHEMBL6366123 0.93 FAAH (0.85) FAAHSOAT1CYP1A2CYP2C19KMT2A
Oleamide SCHEMBL15533927 0.93 FAAH (0.85) FAAHSOAT1CYP1A2CYP2C19KMT2A
Oleamide SCHEMBL19814150 0.92 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL21501560 0.92 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL24340776 0.92 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL21654359 0.92 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL22419041 0.92 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL21983255 0.92 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A
SCHEMBL11853757 0.92 FAAH (1.00) FAAHSOAT1CYP1A2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450294-B2 Shampoo compositions LUBRIZOL ADVANCED MATERIALS, INC. (US) 2013-05-28 US disclosed
EP-1141056-B1 BRANCHED/BLOCK COPOLYMERS FOR TREATMENT OF KERATINOUS SUBSTRATES LUBRIZOL ADVANCED MAT INC (US) 2010-08-25 EP disclosed
US-20090318571-A1 Hydrocolloids and Process Therefor LUBRIZOL ADVANCED MATERIALS, INC. (US) 2009-12-24 US disclosed
EP-1841402-B9 PROCESS FOR PREPARING HYDROCOLLOIDS LUBRIZOL ADVANCED MAT INC (US) 2009-09-16 EP disclosed
US-20090137438-A1 Hydrocolloids and Process Therefor LUBRIZOL ADVANCED MATERIALS, INC. 2009-05-28 US disclosed
EP-1841402-B1 PROCESS FOR PREPARING HYDROCOLLOIDS LUBRIZOL ADVANCED MAT INC (US) 2009-04-22 EP disclosed
EP-1841402-A1 PROCESS FOR PREPARING HYDROCOLLOIDS Lubrizol Advanced Materials, Inc. (US) 2007-10-10 EP disclosed
WO-2006065469-A1 PROCESS FOR PREPARING HYDROCOLLOIDS NOVEON, INC. (US) 2006-06-22 WO disclosed
WO-2006062792-A2 HYDROCOLLOIDS AND PROCESS THEREFOR NOVEON, INC. (US) 2006-06-15 WO disclosed
EP-1639018-A1 GALACTOMANNAN HYDROCOLLOIDS Noveon IP Holdings Corp. (US) 2006-03-29 EP disclosed
EP-0574607-A1 Aqueous aerosol hair spray HELENE CURTIS, INC. (US) 1993-12-22 EP disclosed
US-5248445-A Anionic surfactants for conditioning hair HELENE CURTIS, INC. (US) 1993-09-28 US disclosed
EP-0555690-A1 Stable conditioning shampoo containing fatty acid/fatty alcohol blend HELENE CURTIS, INC. (US) 1993-08-18 EP disclosed
EP-0555691-A1 Stable conditioning shampoo containing fatty acid HELENE CURTIS, INC. (US) 1993-08-18 EP disclosed
EP-0524427-A2 Aqueous hair styling aid HELENE CURTIS, INC. (US) 1993-01-27 EP disclosed
EP-0524346-A1 Composition and method for protecting hair against thermal degradation and to aid in hair styling HELENE CURTIS, INC. (US) 1993-01-27 EP disclosed
EP-0523388-A2 Aerosol hair spray HELENE CURTIS, INC. (US) 1993-01-20 EP disclosed
US-5164177-A Aqueous aerosol or nonaerosol hair spray HELENE CURTIS, INC. (US) 1992-11-17 US disclosed
EP-0467235-A1 Hair conditioning shampoo HELENE CURTIS, INC. (US) 1992-01-22 EP disclosed
US-5078990-A Contain long chain alkyl sulfate and/or ether sulfates, HELENE CURTIS, INC. (US) 1992-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137438-A1 Hydrocolloids and Process Therefor ALG1, GYPA, HSD17B7 FAAH 3220/4885SOAT1 357/4885CYP1A2 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.